Essilor Stellest 2.0 Posts 0.51 D At Six Months — What Myopia-control Evidence Means For Kids' Frame Orders

Sep 23, 2026 Leave a message

Essilor Stellest 2.0 posts 0.51 D at six months - what myopia-control evidence means for kids' frame orders

Leeyewear

kids-optical-frame

On 22 September 2026, EssilorLuxottica reported six-month interim results from an ongoing randomized, double-masked trial in Guangzhou, China, evaluating its Essilor Stellest 2.0 myopia-control lens in children. Against single-vision lenses, the lens slowed myopia progression by 0.51 D and axial elongation by 0.21 mm on average (n=62 vs 58). Wearing compliance held above 12 hours a day, seven days a week, for over 90% of children in both groups, and 98% of children wearing the test lens adapted fully within one week.

 

Two caveats matter before quoting these numbers in a sourcing decision. First, the trial is still running; the prespecified one-year analysis is the primary endpoint, and the six-month readout is interim. Second, the "twice as fast" comparison - 2.0 at six months matching first-generation Stellest at twelve months (0.53 D / 0.23 mm in a separate Wenzhou trial) - is an indirect comparison across two different studies. EssilorLuxottica's own footnotes state no formal between-study statistical test was performed, so treat the speed claim as directional.

 

The 71% figure circulating alongside this news belongs to the previous generation. First-generation Essilor Stellest lenses showed a 71% reduction in myopia progression (0.64 D) and a 53% reduction in axial elongation (0.24 mm) over 24 months in a US trial of 159 children aged 6–12, published in JAMA Ophthalmology in August 2026 and cited in the FDA De Novo authorization for the product. Stellest 2.0 is a separate lens: strong early data from China, not yet FDA-cleared, and not available in the United States. Keep the two evidence chains apart when you brief your product team.

 

The order-side read is on the kids' line. Myopia-control spectacles are worn all day - school, sport, homework - and the lens only does its job if the frame holds it in the right position. That puts three requirements on a kids' optical frame: low weight on a small face, resistance to daily abuse, and accurate sizing so the optical center and lenslet zone stay where they should. TR90, PC and nylon carry the durability load; titanium and beta-titanium bring the weight down and suit children with sensitive skin. For more, read these two articles: Kids Optical Frames: Sourcing Guide for 5 Vision Problems and What type of glasses are good for kids?.

 

Adult frames follow different drivers. Adult buyers replacing a prescription choose on hand feel and daily wear: acetate fronts for surface quality, titanium and metal-alloy builds for lightness and durability. [Leeyewear optical frames category page] Same category, two briefs - the myopia tailwind lands on kids' frames, and the adult line runs on replacement cycles and material upgrades.

 

On our kids' line we produce optical frames in TR90, PC and nylon, with small-batch runs for brands testing a myopia-control range. [Insert: Leeyewear kids' optical frame product name / link] The adult line covers acetate, titanium, carbon fiber and metal-alloy frames, all OEM/ODM for private label. 

 

If you are planning a myopia-control range for next season - kids, adults, or both - send the spec or a reference photo. We will give you a straight answer on materials, weight and lead time.

 

Contact: Rain@leeyewear.com - email us for our kids' optical frames catalog.

Contact now

 

 

Sources:

EssilorLuxottica press release, 22 September 2026 - six-month interim results, Essilor Stellest 2.0, randomized double-masked China trial: https://www.essilorluxottica.com/en/newsroom/press-releases/best-treatment-effects-on-essilor-stellest-lenses

JAMA Ophthalmology, August 2026 - 24-month US trial of first-generation Essilor Stellest lenses, 71% reduction in myopia progression 

https://doi.org/10.1001/jamaophthalmol.2026.3288

EssilorLuxottica press release, 27 August 2026 - 24-month US clinical trial results supporting FDA De Novo authorization: https://www.essilorluxottica.com/en/newsroom/press-releases/24-month-us-clinical-trial-results-essilor-stellest-lenses/

Essilor® and Stellest® are trademarks of EssilorLuxottica. Data cited above are from the company's public disclosures; this article discusses frame sourcing and makes no treatment claims.